SHELTON, CONNECTICUT / ACCESS Newswire / February 12, 2026 / NanoViricides, Inc., a publicly traded company (NYSE ...

After the advent of gene-editing technology, if it can lead to disease treatment, the question naturally moves to the next ...

Humans develop sharp vision during early fetal development thanks to an interplay between a vitamin A derivative and thyroid hormones in the retina, Johns Hopkins University scientists have found. The ...

Johnson & Johnson (NYSE: JNJ) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for subcutaneous amivantamab and hyaluronidase-lpuj as ...

Glaukos Corporation (NYSE:GKOS) Q4 2025 Earnings Call Transcript February 17, 2026 Glaukos Corporation misses on earnings ...

Thank you for standing by, and welcome to the Krystal Biotech 4Q 2025 Conference Call. [Operator Instructions] As a reminder, today's conference is being recorded. I would now like to hand the ...

We Don’t Know if the Models Are Conscious’ transcript I want to try and focus on scenarios where A.I. goes rogue. I should have had a picture of a Terminator robot to scare people as much as possible.

Breast Cancer Expert Committee of Chinese Society of Clinical Oncology, Breast Cancer Professional Committee of China Anti-Cancer Association.

The White House on Tuesday rejected the latest offer from Democratic lawmakers on proposed new constraints on federal ...

MTX240's mechanistic novelty may give it a long-awaited edge in treatments for gastrointestinal stromal tumors (GIST)Meg Flippin, Benzinga Staff Writer CARDIFF, UK / ACCESS Newswire / February 19, 202 ...

Krystal Biotech, Inc. (NASDAQ:KRYS) Q4 2025 Earnings Call Transcript February 17, 2026 Krystal Biotech, Inc. beats earnings ...

Latest updates from the BBC's specialists in fact-checking, verifying video and tackling disinformation.